
NYSEHealthcareMedical - Diagnostics & Research
最新資料
US$230.97
+US$0.16 · +0.07%
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
前收盤價
US$230.97
+US$0.16 · +0.07%
盤前
US$230
−US$0.97 · -0.42%
10月12日 上午7:00 ET
盤中時間採用ET。市場資料可能有所延遲。
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
日內區間
目前US$230.97
52週區間
目前US$230.97
盤中時間採用ET。市場資料可能有所延遲。
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
日內區間
目前US$230.97
52週區間
目前US$230.97
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(USD) | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 110.35億 USD | 98.72億 USD | 92.52億 USD | 98.83億 USD | 107.88億 USD |
| 銷貨成本 | 75.12億 USD | 66.28億 USD | 61.99億 USD | 64.5億 USD | 65.79億 USD |
| 毛利 | 35.23億 USD | 32.44億 USD | 30.69億 USD | 34.33億 USD | 42.09億 USD |
| 銷售、一般及管理費用 | 19.67億 USD | 17.7億 USD | 16.15億 USD | 18.74億 USD | 17.27億 USD |
| 營業費用 | 19.2億 USD | 18.98億 USD | 18.07億 USD | 20.05億 USD | 18.28億 USD |
| 利息收入 | 1300萬 USD | 2500萬 USD | 1100萬 USD | 1000萬 USD | 100萬 USD |
| 利息支出 | 2.77億 USD | 2.26億 USD | 1.63億 USD | 1.48億 USD | 1.52億 USD |
| 折舊和攤銷 | 5.7億 USD | 4.93億 USD | 4.39億 USD | 4.37億 USD | 4.08億 USD |
| 營業利益 | 16.03億 USD | 13.46億 USD | 12.62億 USD | 14.28億 USD | 23.81億 USD |
| 淨利 | 9.92億 USD | 8.71億 USD | 8.54億 USD | 9.46億 USD | 19.95億 USD |
公司資料更新於 2026年10月12日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動,並非 GoAI 建議。
報告持有此股票曝險的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T495.13億0.04%129.43兆 JPY0.09%¥122,850+0.12%
Vanguard Morningstar Total Stock Market ETFVTI8.45億0.04%2.3兆 USD0.03%US$381.94+0.63%
Vanguard S&P 500 ETFVOO7.07億0.04%1.8兆 USD0.03%US$715.59+0.61%
Vanguard Morningstar Mid-Cap ETFVO5.75億0.25%2264億 USD0.03%US$81.14+0.92%
iShares Core S&P 500 ETFIVV3.39億0.04%8964.4億 USD0.03%US$781.97+0.60%
State Street SPDR S&P 500 ETFSPY3.13億0.04%8172億 USD0.09%US$778.57+0.60%
Vanguard Morningstar Value ETFVTV2.54億0.10%2624億 USD0.03%US$220.59+0.44%
Invesco S&P 500 Equal Weight ETFRSP1.93億0.20%977.83億 USD0.20%US$213.04+0.55%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Mid-Cap ETFVO
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
Vanguard Morningstar Value ETFVTV
Invesco S&P 500 Equal Weight ETFRSPAI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。